Acasă › Cancer pulmonar cu celule non-pătrate › Illinois › Waukegan
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Waukegan, IL
16 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Waukegan (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · La 10 mi distanță
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- City of Hope Chicago, Zion · La 6 mi distanță
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · La 8 mi distanță
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · La 3 mi distanță
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- City of Hope® Cancer Center Chicago, Zion · La 6 mi distanță
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
În curs de recrutareFaza 3
- Research Site, Zion · La 6 mi distanță
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, North Chicago · La 3 mi distanță
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
În curs de recrutareFaza 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · La 10 mi distanță
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
În curs de recrutareFaza 3
- Cancer Treatment Centers of America (CTCA), Zion · La 6 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
- și încă 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
- și încă 1
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
- și încă 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · La 10 mi distanță
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
În curs de recrutareFaza 2
- City of Hope at Chicago, Zion · La 6 mi distanță
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Waukegan
- Cancer pulmonar16 studii
- Cancer de sân12 studii
- Colită ulcerativă7 studii
- Cancer renal (carcinom cu celule renale)7 studii
- Cancer ovarian6 studii
- Cancer metastatic6 studii
- Carcinom cu celule scuamoase de cap și gât6 studii
- Cancer colorectal6 studii
- Cancer de prostată6 studii
- Melanom5 studii
- Leucemie mieloasă acută5 studii
- Boala Crohn5 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.